CLOSEOUT LETTER
Diversified Pharmacy Inc dba University Compounding Pharmacy MARCS-CMS 470499 —
- Recipient:
- Diversified Pharmacy Inc dba University Compounding Pharmacy
United States
- Issuing Office:
United States
|
|
|
|
Division of Pharmaceutical Quality Operations III
300 River Place, Suite 5900 Detroit, MI 48207 Telephone: (313) 393-8100 Fax: (313) 393-8139 |
September 12, 2018
UPS NEXT DAY
SIGNATURE REQUIRED
Joseph J. McCloskey
Owner
Diversified Pharmacy, Inc., dba
University Compounding Pharmacy
2520 Livernois Road
Troy, MI 48083-4703
Dear Mr. McCloskey:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (ref: WL 2016 DET-07) dated February 26, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Compliance Director
Division of Pharmaceutical Quality Operations III